Overview Fundamentals API Earnings EOD API Sample Code Pricing

Mineralys Therapeutics Inc. Common Stock (MLYS NASDAQ) stock market data APIs

$13.84 -0.64(-4.4%) as of July 12, 2024
Price chart is built with Anychart

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.

Mineralys Therapeutics Inc. Common Stock Financial Data Overview

563 M
49 649 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'MLYS',
Type: 'Common Stock',
Name: 'Mineralys Therapeutics Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00ZXN1GN3',
CIK: '1933414',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-02-10',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Mineralys Therapeutics Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -2.18
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Mineralys Therapeutics Inc. Common Stock Earnings via APIs

  • Latest Release 2024-05-13
  • EPS/Forecast -0.72

Get Mineralys Therapeutics Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?